133
Views
5
CrossRef citations to date
0
Altmetric
Original Articles

Identification of Urinary Metabolites of Orally Administered N,N-Dimethyl-p-Toluidine in Male F344 RatsFootnote

, , , , &
Pages 781-788 | Received 12 Apr 2006, Accepted 25 Jul 2006, Published online: 17 Apr 2007
 

Abstract

The metabolism of orally administered N,N-dimethyl-p-toluidine (DMPT) in male F344 rats was investigated. The rat urinary metabolite profile was determined by analytical reverse-phase high performance liquid chromatography (HPLC). Four radiolabeled peaks were observed, isolated, and purified by solid-phase extraction (SPE) and preparative HPLC methods. The 4 peaks were identified as p-(N-acetylhydroxyamino)hippuric acid (M1), DMPT N-oxide (M2), N-methyl-p-toluidine (M3), and parent DMPT. Metabolites M1 and M2 were identified by spectrometric and spectroscopic methods, including mass fragmentation pattern identification from both liquid chromatography/mass spectrometry and gas chromatography/mass spectrometry, and from chemical analysis of nuclear magnetic resonance spectra. Structural confirmation of metabolite M2 was accomplished by comparison with a synthetic standard. Peaks M3 and the peak suspected to be DMPT were identified by comparison of their HPLC retention times and mass fragmentation patterns with authentic standards of N-methyl-p-toluidine and DMPT, respectively. DMPT metabolism is similar to that reported for N,N-dimethylaniline.

ACKNOWLEDGMENTS

This work was supported by Contract Number N01-ES-25483 from the NIEHS. We thank Dr. L.T. Burka at NIEHS for his critical review of the manuscript. We thank Dr. Karen Ann Smith in the Department of Chemistry, University of New Mexico, for her assistance with the NMR experiments. We also thank Mark Gurule, Briana Hedtke-Weber, and Krystal Pacheco of Lovelace Respiratory Research Institute for technical assistance and Ms. Vicki Fisher for assistance with manuscript preparation.

Notes

∗This manuscript has not been published elsewhere and has not been submitted simultaneously for publication elsewhere.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.